Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Miles Ingrey-CounterGeneral Counsel & Company Secretary | 1,04k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-05-15 | Mr. Andrew Gregory LewisInterim CFO | 2,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-05-15 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-14 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,00k | 31,23k | Acquisto | 15,62 | 45,12k | 4,64% |
| 2026-01-05 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 9,34k | 0,00 | Derivative Exercise and Retained Stock | - | 43,12k | 27,64% |
| 2026-01-05 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | -8,34k | 145,84k | Derivative Exercise and Sale | 17,48 | 43,12k | - |
| 2026-01-05 | Mr. Dan ClarkGroup President of Simulation | 1,22k | 0,00 | Derivative Exercise and Retained Stock | - | 1,22k | - |
| 2026-01-05 | Mr. Dan ClarkGroup President of Simulation | -1,09k | 19,07k | Derivative Exercise and Sale | 17,48 | 1,22k | - |
| 2026-01-05 | Mr. Andrew NgGroup President of Testing Products | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 2,95k | - |
| 2026-01-05 | Mr. Andrew NgGroup President of Testing Products | -2,64k | 46,08k | Derivative Exercise and Sale | 17,48 | 2,95k | - |
| 2026-01-05 | Mr. Matthew PriceGroup Corporate Development Director | 1,97k | 0,00 | Derivative Exercise and Retained Stock | - | 4,15k | 90,75% |
| 2026-01-05 | Mr. Matthew PriceGroup Corporate Development Director | -1,76k | 30,80k | Derivative Exercise and Sale | 17,48 | 4,15k | - |
| 2025-11-17 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,69k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 55,87k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Andrew NgGroup President of Testing Products | 16,99k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Matthew PriceGroup Corporate Development Director | 6,71k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Dan ClarkGroup President of Simulation | 11,68k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Neil CarpenterManaging Director of Testing Services | 8,83k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Ben RussellInsider | 9,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Rory GrunerudManaging Director of ABD Solutions | 8,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-09 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 1.000,00 | 20,97k | Acquisto | 20,97 | 31,09k | 3,32% |
| 2025-06-05 | Mr. Anthony BestInsider | -90,00k | 2,13M | Vendita | 23,63 - 23,74 | 5,39M | -1,64% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
